[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"degenerative-myelopathy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:degenerative-myelopathy":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100462071",false,"NCT05296889","Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical","Multicenter Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical - a Prospective Study on Total Indications","CERISE","Inclusion Criteria:\n\n* Patient is minimum 18 years old\n* Informed Consent in the documentation of clinical and radiological results\n* Patient has indication according to Instructions for Use (IFU)\n* Patient is not pregnant\n\nExclusion Criteria:\n\n* Patient's clear unability or unwillingness to participate in follow-up examinations","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications",[24,25,26,27,28],"Spine Fracture","Degenerative Disc Disease","Spinal Instability","Spinal Tumor","Degenerative Myelopathy",[30],"Cervical Spine","RECRUITING","2026-03-26",{"date":34,"type":35},"2026-03-31","ACTUAL",{"date":37,"type":35},"2021-07-21",{"date":39,"type":20},"2026-07",{"name":41,"class":42},"Aesculap AG","INDUSTRY",4,""]